Know What's Happening in Earnings Calls
Know What's Happening in Earnings Calls
Micron posts $23.9B revenue, AI memory outlook split
Micron Technology reported fiscal Q2 revenue of $23.86 billion, nearly tripling year‑over‑year, and posted non‑GAAP earnings of $12.20 per share. Citi responded by cutting its price target to $425 from $510, sparking a debate among analysts about the durability of the AI‑driven memory boom.
Ducommun reported a record $212.6 million Q3 revenue, up 6% year‑over‑year, and achieved a new high gross margin of 26.6%. The defense segment drove growth, expanding 13% with missiles up 21%, while commercial aerospace fell 10% amid Boeing and Spirit destocking. A $99.7 million litigation charge produced a GAAP loss of $64.4 million, but adjusted earnings held steady at $0.99 per share. Backlog reached a record $1.03 billion, giving a book‑to‑bill ratio of 1.6 and supporting reaffirmed mid‑single‑digit revenue guidance for 2025.
Shenandoah Telecommunications reported Q2 2025 revenue of $88.6 million, driven by a 40.5% jump in Glo Fiber sales to $19.8 million and a record addition of 5,700 new fiber subscribers. Adjusted EBITDA climbed 21.9% to $28.4 million, lifting the margin to 32% as...
NCR Voyix reported Q4 2025 revenue of $720 million, a 6% increase year‑over‑year, with adjusted EBITDA rising 17% to $130 million and margin expanding to 18.1%. Retail revenue grew 9% while the restaurant segment remained flat, and platform sites reached 80,000, up...
Hilton Grand Vacations reported fourth‑quarter 2020 revenue of $233 million, a 5% sequential increase, and adjusted EBITDA of $35 million (excluding a $3 million CARES Act credit). The company posted a net loss of $143 million, driven by a $209 million non‑cash land impairment. Contract...
Tecnoglass Inc. trimmed its 2025 revenue midpoint guidance by $20 million after commercial construction invoicing slowed, with roughly half of the shortfall expected to roll into 2026. The company faces sharply higher aluminum input costs—LME prices up 15% and U.S. premiums...
AvePoint reported Q4 2025 revenue of $114.7 million, up 29% year‑over‑year, driven by SaaS revenue of $88.9 million representing 78% of total sales. Annual recurring revenue climbed to $416.8 million, with net new ARR of $26.8 million—a 48% increase and a record quarter. The...
Amphastar Pharmaceuticals reported full‑year 2025 net revenues of $719.9 million, a modest 2% decline, while its flagship product Baqsimi grew 12% to $185.4 million. The company secured FDA approval for ipratropium bromide HFA (AMP‑007), gaining 180‑day generic exclusivity, and announced a major...
Kimbell Royalty Partners reported Q4 2025 production of 25,627 BOE per day and adjusted EBITDA of $64.8 million, while proved reserves rose 8% to a record 73 million BOE. The company declared a $0.37 per unit distribution, a 6% increase, classified entirely as return of...
Where Food Comes From Inc. posted a modest revenue dip to $7 million in the quarter, down $92,000 year‑over‑year, but net income more than doubled to $1.1 million thanks largely to a $946,000 gain from the Progressive Beef sale. Verification and certification...
Privia Health reported a robust 2025, with implemented providers rising 12.3% to 5,380 and attributed lives increasing 22.7% to 1.54 million. Practice collections grew 16.9% to $3.47 billion and adjusted EBITDA surged 38.8% to $125.5 million, delivering a 130% free‑cash‑flow conversion. The company...
MSCI Inc. reported double‑digit organic revenue growth of over 10% in Q4 2025, accompanied by adjusted EBITDA up more than 13% and adjusted EPS rising nearly 12% quarter‑over‑quarter. The company’s subscription run rate topped $3.3 billion, driven by an 18% surge...
OPKO Health reported a $369 million cash position for Q4 2025, driven by asset sales, BARDA funding and partnership payments. The company repurchased 34.6 million shares for $47 million and allocated $109 million to stock and convertible note buybacks. Diagnostics revenue dropped to $71.1 million, but...
Morgan Stanley delivered record 2025 results, posting $70.6 billion in total revenue and a historic $10.21 earnings per share. Total client assets rose to $9.3 trillion, while wealth management generated $31.8 billion in revenue and attracted $356 billion of net new assets. The firm’s...
Progyny reported record fiscal 2025 revenue of $1.29 billion, a 10% increase year‑over‑year, and adjusted EBITDA of $222 million, both surpassing guidance midpoints. Operating cash flow rose 17% to $210 million, while gross margin improved by nearly 200 basis points due to care‑management...
PolyPid announced successful completion of the Phase III SHIELD II trial, with D‑PLEX100 achieving its primary and key secondary endpoints and demonstrating a meaningful reduction in surgical site infections. The FDA provided written support for a rolling NDA review, and the company...
PRA Group reported record financial results for 2025, with estimated remaining collections (ERC) reaching $8.6 billion, cash collections $2.1 billion and revenue $1.2 billion, all new highs. Portfolio purchases totaled $1.2 billion, matching its target and driving higher purchase‑price multiples in both the U.S....
Ligand Pharmaceuticals reported a breakout 2025, delivering $268 million total GAAP revenue and $240 million core revenue, driven by a 48% surge in royalty income. Adjusted earnings per share rose 42% to $8.13, surpassing guidance by more than 30%, while cash and...
TriMas Corp reported third‑quarter 2025 net sales of $269 million, a 17% year‑over‑year increase driven by 16% organic growth and strong aerospace performance. Operating profit rose 34% to $30.3 million and adjusted EBITDA climbed 25% to $48 million, while adjusted EPS jumped 42%...
Xponential Fitness reported Q3 2025 adjusted EBITDA of $33.5 million, up 9% year‑over‑year, with a margin expanding to 42%. Consolidated revenue slipped 2% to $78.8 million, driven by a 49% plunge in equipment sales and softer merchandise demand. Franchise revenue rose 17%...
Papa John’s reported a 1% drop in global system‑wide sales for Q4 2025, with North America comparable sales falling 5% while international markets rose 6%, led by a 7% gain in the UK. Total revenue slipped 6% to $498 million and...
Wolverine World Wide reported full‑year 2025 revenue of $1.874 billion, a 7% increase, and adjusted EPS of $1.35, up 53% year‑over‑year. Gross margin expanded to 47.3% driven by lower supply‑chain costs and tariff mitigation, while net debt fell $81 million to $415 million....
Perrigo reported a 4.4% decline in organic net sales for the quarter, driven by softness in global OTC and its infant formula and oral‑care businesses under review. Despite the downturn, the company gained 90 basis points of US store‑brand OTC...
DoubleVerify reported a 15% year‑over‑year revenue increase to $657 million in 2024, driven by double‑digit growth across measurement, activation and a 25% surge in supply‑side revenue. The company recorded a record $8.3 trillion in billable media transactions and delivered a 33% adjusted...
MDxHealth reported Q4 2025 revenue of $29.5 million, a 19% year‑over‑year increase, driven primarily by a 128% surge in liquid‑based test volume. Gross profit rose 20% to $18.7 million, while operating loss widened to $5.3 million and net loss expanded...
Organogenesis Holdings posted a record fourth‑quarter 2025, delivering $225.1 million in net product revenue, a 78% year‑over‑year increase driven largely by an 83% surge in advanced wound‑care sales. Gross profit rose to 78% of revenue and GAAP operating income jumped 519%...
Concentrix reported fourth‑quarter 2025 revenue of $2.55 billion, a 3.1% constant‑currency increase that exceeded the high end of guidance. Non‑GAAP operating income rose to $323 million with a 12.7% margin, and adjusted free cash flow reached $626 million for the year, up 32%,...
Hagerty Inc. reported Q3 2025 revenue of $380 million, an 18% year‑over‑year increase, propelled by 16% written‑premium growth and strong State Farm policy conversions. Operating profit jumped 240% to $34 million, lifting margins to 9% and net income to $46 million, a 143%...
Compania de Minas Buenaventura reported Q2 2025 EBITDA of $130 million and net income of $91 million, driven by a 28% rise in copper output while silver and gold fell 11% and 17% respectively. The San Gabriel project reached 88% completion with $82 million CapEx...
Vistance Networks completed the CCS divestiture to Amphenol, using the proceeds to retire all debt, redeem preferred equity and declare a $10‑per‑share special cash distribution. The company posted a 40% jump in full‑year net sales to $1.93 billion, with Q4 core...
PAR Technology reported Q4 2025 revenue of $120.1 million, up 14% year over year, driven by strong subscription services and modest hardware growth. Annual recurring revenue reached $315.4 million, a 15% organic increase, with subscription revenue representing 63% of total. The company...
USA TODAY Co. reported Q4 2025 revenue of $585 million, down 5.8% year‑over‑year, while adjusted EBITDA rose 16.6% to $91.1 million, marking its strongest profitability in four years. Digital revenues hit an all‑time high, representing 47% of total revenue and driving a...
Zscaler reported Q1 FY2026 revenue of $788 million, a 20% year‑over‑year increase, and annual recurring revenue (ARR) surpassing $3.2 billion, up 26% YoY. AI‑security ARR exceeded its $400 million target three quarters early, growing over 80% and is projected to top $500 million by...
Fortrea Holdings posted fourth‑quarter 2025 revenue of $660.5 million, a 5.2% year‑over‑year decline, while full‑year revenue rose modestly 1% to $2.723 billion. Adjusted EBITDA fell to $54 million in Q4 but the full‑year $189.9 million remained near the top of guidance, supported by aggressive...
Cytek Biosciences reported Q3 2025 revenue of $52.3 million, a modest 2% year‑over‑year increase driven by strong APAC growth and expanding recurring service and reagent streams. The company posted a net loss of $5.5 million and adjusted EBITDA of $2.5...
Solventum Corp reported Q4 FY2025 results, posting 3.5% organic sales growth and $2.0 billion in revenue, though reported sales fell 3.7% because of the Purification & Filtration divestiture and the Acera acquisition. Gross margin slipped to 53.5% and adjusted operating income...
Heron Therapeutics reported full‑year 2025 net product sales of $155 million and adjusted EBITDA of $14.7 million, surpassing its guidance. Acute Care drove growth, with ZYNRELEF revenue up 48% YoY and the franchise expanding 57% overall, helped by the CrossLink IGNITE incentive program,...
Installed Building Products reported a record $778 million in Q3 2025 revenue, up 2% year‑over‑year, driven by a 30% surge in heavy‑commercial sales. Adjusted EBITDA reached a new high of $140 million, delivering an 18% margin, while adjusted gross margin...
Nautilus Biotechnology reported a 23% drop in operating expenses to $15.4 million for Q4 2025, driven by lower R&D and administrative costs, while ending the quarter with $156.1 million in cash and a reduced cash burn of $50.2 million. The...
Hepsiburada reported a 57% year‑on‑year increase in gross merchandise volume (GMV) and 63% revenue growth for Q2 2022 on an unadjusted basis, but inflation‑adjusted figures showed a 10% GMV decline and a 6% revenue dip. The company posted positive free cash...
EnPro Industries reported a strong fourth‑quarter 2025, with revenue climbing 14.3% to $295.4 million and adjusted EBITDA rising 19.2% to $69.4 million, delivering adjusted diluted EPS of $1.99, up nearly 27%. Both Sealing Technologies and Advanced Surface Technologies posted double‑digit sales growth,...
J.M. Smucker reported a $75 million coffee tariff hit in Q3, which will flip to a tailwind in FY 2027, while its Sweet Baked Snacks segment beat top‑line expectations but missed profit targets due to transition costs. The company lowered full‑year net‑sales...
Castle Biosciences reported $344.2 million revenue for 2025, beating its own guidance, and projected $340‑$350 million for 2026. Core test volumes surged, with TissueCypher reports up 86% to 39,014 and total reports reaching 105,053, while DecisionDx‑Melanoma grew modestly 9%. The company posted...
Daqo New Energy reported a 39.7% drop in annual polysilicon production to 123,652 metric tons, staying within its guided range, while sales outpaced output at 126,707 tons. Revenue fell 35% to $665 million and average selling price slipped 7.2%, yet the...
Fox Factory reported fiscal Q4 2025 revenue of $361.1 million, a 2.3% increase, and full‑year sales of $1.47 billion, up 5.3%. Gross margin slipped to 28.3% from 28.9% amid product‑mix shifts and tariff headwinds, and the company recorded a $295 million non‑cash...
Asure Software reported Q3 2025 revenue of $36.3 million, a 24% year‑over‑year increase, driven by strong growth across payroll, benefits, recruiting and time‑and‑attendance solutions. Recurring revenue rose 11% to $31.8 million, while professional services and hardware revenue jumped to $4.4...
Palmer Square Capital BDC reported Q3 2025 results, deploying $138.7 million of capital across 28 new commitments while generating $13.6 million of net investment income that fully covered its $0.42 per‑share total dividend. The firm posted a NAV of $15.39 per share, reaffirmed...
Align Technology reported a record $1.05 billion Q4 2025 revenue, up 5.3% year‑over‑year, driven by strong clear‑aligner sales and expanding Systems & Services. Non‑GAAP operating margin improved to 26.1%, the highest since 2021, while cash balances rose to $1.09 billion. The company...
MP Materials announced a $400 million convertible preferred equity investment and a $150 million low‑interest loan from the U.S. Department of Defense, making the DOD its largest shareholder. The company set a $110 per‑kilogram price floor for NDPR‑containing products and will expand U.S....
Warby Parker reported FY2024 revenue growth exceeding 15% and a 40% jump in adjusted EBITDA, driven by its strongest Q4 growth since 2021. The company opened 41 new stores in 2024, expanded its insurance network to over 30 million in‑network lives,...
Navient reported Q4 2025 core EPS of $0.02 and a full‑year core loss of $0.35 per share, while exceeding its $400 million expense‑reduction target, delivering a 40% drop in operating costs and adding $2 billion of projected future cash flow. Earnest’s loan...
